A restricted repertoire of De Novo Mutations in ITPR1 cause Gillespie Syndrome with evidence for dominant negative effect
A restricted repertoire of De Novo Mutations in ITPR1 cause Gillespie Syndrome with evidence for dominant negative effect
Gillespie syndrome (GS) is characterized by bilateral iris hypoplasia, congenital hypotonia, non-progressive ataxia, and progressive cerebellar atrophy. Trio-based exome sequencing identified de novo mutations in ITPR1 in three unrelated individuals with GS recruited to the Deciphering Developmental Disorders study. Whole-exome or targeted sequence analysis identified plausible disease-causing ITPR1 mutations in 10/10 additional GS-affected individuals. These ultra-rare protein-altering variants affected only three residues in ITPR1: Glu2094 missense (one de novo, one co-segregating), Gly2539 missense (five de novo, one inheritance uncertain), and Lys2596 in-frame deletion (four de novo). No clinical or radiological differences were evident between individuals with different mutations. ITPR1 encodes an inositol 1,4,5-triphosphate-responsive calcium channel. The homo-tetrameric structure has been solved by cryoelectron microscopy. Using estimations of the degree of structural change induced by known recessive- and dominant-negative mutations in other disease-associated multimeric channels, we developed a generalizable computational approach to indicate the likely mutational mechanism. This analysis supports a dominant-negative mechanism for GS variants in ITPR1. In GS-derived lymphoblastoid cell lines (LCLs), the proportion of ITPR1-positive cells using immunofluorescence was significantly higher in mutant than control LCLs, consistent with an abnormality of nuclear calcium signaling feedback control. Super-resolution imaging supports the existence of an ITPR1-lined nucleoplasmic reticulum. Mice with Itpr1 heterozygous null mutations showed no major iris defects. Purkinje cells of the cerebellum appear to be the most sensitive to impaired ITPR1 function in humans. Iris hypoplasia is likely to result from either complete loss of ITPR1 activity or structure-specific disruption of multimeric interactions.
981-992
McEntagart, M.
149119b2-ef4b-4082-b173-5c2929d76da8
Williamson, K.A.
bd7c33f1-a74d-4027-af70-12e27f407606
Rainger, J.K.
059a1349-e9a9-45e9-8181-b61fd4118e2f
Wheeler, A.
eb831100-6e51-4674-878a-a2936ad04d73
Seawright, A.
e507d40c-d819-478a-af6e-9a4685e68df6
De Baere, E.
cda99baf-dfd1-43c1-ba5d-f4e03cbe94bf
Verdin, H.
d3be7369-2368-49ed-a8da-d86117292547
Bergendahl, L. T.
95fb73bb-262c-470f-808a-b388f77881c8
Quigley, A.
290eae9a-953d-424c-83b2-0c0f969c63f5
Rainger, J.
af2f10a4-d22a-4ec3-aa7c-965eaa813453
Dixit, A.
d6b2cef3-ba34-4e51-bd3f-1fa5db51982d
Sarkar, A.
266aea3b-84d4-443d-ba99-4c686683946e
Lopez Laso, E.
8e05e596-5731-499d-80e5-8cfe1e825ef9
Sanchez-Carpintero, R.
d30f3135-a0f1-4aab-acd1-3127c0920349
Barrio, J.
96efa403-6004-40f4-8e00-d734c822556f
Bitoun, P.
83481c17-9665-4915-ba01-8a6cbaba4d0b
Prescott, T.
f663a4d7-5e26-4092-b2db-fcc7651045d5
Riise, R.
2bf502b3-537f-4658-b685-18ab87e4fd04
McKee, S.
fd8994ab-2359-4a29-909c-581a45b025a0
Cook, J.
45c40993-978e-496e-9922-65774f13985e
McKie, L.
17b0ceed-609a-4101-b3f1-dd2c774a6a1a
Ceulemans, B.
f7ad3b1e-176d-4c2f-81d1-6fbfab84c190
Meire, F.
08f188e7-83a4-41be-9090-5f88eef4a653
Temple, I.K.
d63e7c66-9fb0-46c8-855d-ee2607e6c226
Prieur, F.
b4e2ee8e-9e38-4497-b89a-0312f729c952
Williams, J.
35d751d3-e792-4ce2-a5f5-fd34678a5488
Clouston, P.
d79813cb-b6c8-4405-a673-b46fd75f300c
Nemeth, A.H.
359ed8cc-2d33-44af-a0ec-3ffc421edaef
Banka, S.
d7429241-8a5d-4a5d-b959-ea6810680fd0
Bengani, H.
76776439-50bd-42fc-a14f-e953a0d4b1f1
Handley, M.
4fdf5b0a-9a30-49e2-af2d-979705da9573
Freyer, E.
1ff619c5-09ff-4aab-8db0-59f9fd3d75e9
Ross, A.
31d232df-e682-4729-b7d3-af01277fed01
van Heyningen, V.
60f186ce-d41d-46e5-a63e-29dbd24501b4
Marsh, J.A.
d3f0062f-600f-48b2-8ff8-ddba7a09390d
Elmslie, F.
b0a78066-91b7-4072-abe8-af9f0b37dfbb
FitzPatrick, D.R.
364a647d-d86f-4f41-929a-7bed338b4250
5 May 2016
McEntagart, M.
149119b2-ef4b-4082-b173-5c2929d76da8
Williamson, K.A.
bd7c33f1-a74d-4027-af70-12e27f407606
Rainger, J.K.
059a1349-e9a9-45e9-8181-b61fd4118e2f
Wheeler, A.
eb831100-6e51-4674-878a-a2936ad04d73
Seawright, A.
e507d40c-d819-478a-af6e-9a4685e68df6
De Baere, E.
cda99baf-dfd1-43c1-ba5d-f4e03cbe94bf
Verdin, H.
d3be7369-2368-49ed-a8da-d86117292547
Bergendahl, L. T.
95fb73bb-262c-470f-808a-b388f77881c8
Quigley, A.
290eae9a-953d-424c-83b2-0c0f969c63f5
Rainger, J.
af2f10a4-d22a-4ec3-aa7c-965eaa813453
Dixit, A.
d6b2cef3-ba34-4e51-bd3f-1fa5db51982d
Sarkar, A.
266aea3b-84d4-443d-ba99-4c686683946e
Lopez Laso, E.
8e05e596-5731-499d-80e5-8cfe1e825ef9
Sanchez-Carpintero, R.
d30f3135-a0f1-4aab-acd1-3127c0920349
Barrio, J.
96efa403-6004-40f4-8e00-d734c822556f
Bitoun, P.
83481c17-9665-4915-ba01-8a6cbaba4d0b
Prescott, T.
f663a4d7-5e26-4092-b2db-fcc7651045d5
Riise, R.
2bf502b3-537f-4658-b685-18ab87e4fd04
McKee, S.
fd8994ab-2359-4a29-909c-581a45b025a0
Cook, J.
45c40993-978e-496e-9922-65774f13985e
McKie, L.
17b0ceed-609a-4101-b3f1-dd2c774a6a1a
Ceulemans, B.
f7ad3b1e-176d-4c2f-81d1-6fbfab84c190
Meire, F.
08f188e7-83a4-41be-9090-5f88eef4a653
Temple, I.K.
d63e7c66-9fb0-46c8-855d-ee2607e6c226
Prieur, F.
b4e2ee8e-9e38-4497-b89a-0312f729c952
Williams, J.
35d751d3-e792-4ce2-a5f5-fd34678a5488
Clouston, P.
d79813cb-b6c8-4405-a673-b46fd75f300c
Nemeth, A.H.
359ed8cc-2d33-44af-a0ec-3ffc421edaef
Banka, S.
d7429241-8a5d-4a5d-b959-ea6810680fd0
Bengani, H.
76776439-50bd-42fc-a14f-e953a0d4b1f1
Handley, M.
4fdf5b0a-9a30-49e2-af2d-979705da9573
Freyer, E.
1ff619c5-09ff-4aab-8db0-59f9fd3d75e9
Ross, A.
31d232df-e682-4729-b7d3-af01277fed01
van Heyningen, V.
60f186ce-d41d-46e5-a63e-29dbd24501b4
Marsh, J.A.
d3f0062f-600f-48b2-8ff8-ddba7a09390d
Elmslie, F.
b0a78066-91b7-4072-abe8-af9f0b37dfbb
FitzPatrick, D.R.
364a647d-d86f-4f41-929a-7bed338b4250